Rifaximin for Pertuzumab-Related GI Toxicities

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2017.00168
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Late GI and Bladder Toxicities After Radiation for Uterine Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2011English

Cutaneous Toxicities From Transplantation-Related Medications

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Rifaximin for Sickle Cell Disease

American Journal of Hematology
Hematology
2019English

Rifaximin for Inflammatory Bowel Disease

Digestive Diseases and Sciences
PhysiologyGastroenterology
2010English

Cancer in Older Adults: Understanding Cause and Effects of Chemotherapy-Related Toxicities

Future Oncology
MedicineCancer ResearchOncology
2019English

Safety, Efficacy, and Patient Acceptability of Rifaximin for Hepatic Encephalopathy

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2014English

Rifaximin Induced Hyponatremia: A Case Report

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2016English

Magnetic Resonance for Quantitative Assessment of Liver Steatosis: A New Potential Tool to Monitor Antiretroviral-Drug-Related Toxicities

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

GI-Veranstaltungskalender

Informatik-Spektrum
Computer Science ApplicationsInformation Systems
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy